Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
16
×
boston
16
×
boston blog main
deals
16
×
life sciences
national blog main
boston top stories
clinical trials
fda
national top stories
investing
san francisco blog main
startups
roche
new york blog main
san francisco top stories
alexion pharmaceuticals
eli lilly
medical device
autoimmune disorders
boehringer ingelheim
clinical trial
drug delivery
genentech
hepatitis b
indiana blog main
medical devices
medtronic
new york top stories
perceptive advisors
rna interference
san diego blog main
vc
venture capital
480 biomedical
abbott laboratories
abbvie
adel malek
akouos
allergan
What
medicines
therapeutics
deal
developing
drug
new
roche
startup
biotech
called
device
disease
fda
gene
million
pharma
research
treat
acquire
address
ago
approval
billion
candidate
company
dicerna
ipo
lands
medical
medicine
morning
pact
patients
pay
pharmaceuticals
potential
raised
recently
rna
team
Language
unset
Current search:
boston
×
biotech
×
deals
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine